Programme

  1. Registration

  2. Welcome and introduction by the moderator

  3. Session 1: Overviews

  4. Updates from the European Commission on BPR

    • Extension of review programme 
    • Anticoagulant rodenticides 
    • Early review of iodine and PVP-iodine 
    • Other updates on active substances 
  5. ECHA overview  

    • Active substance approval and union authorisation: progress and process developments 
    • Technical/scientific requests from the European Commission and lessons learnt 
    • General update on guidance development 
    • IT tools development 
  6. Ten years of the BPR from a member state perspective

    • Organisation of evaluation work in Austria 
    • Experiences in active substance evaluation  
    • Challenges in the authorisation process 
  7. Ten years of the BPR – trends in the biocides market

  8. Q&A

  9. Refreshment break

  10. Session 2: Regulatory developments in the European biocides sector

  11. Ctgb experiences with harmonising mutual recognition procedures under the BPR

    • National applications and mutual recognition 
    • Lack of harmonisation in PTs and search for harmonisation in referral procedures 
    • Ctgb experiences with BPR referrals in the past 10 years  
  12. Lessons from the covid crisis

  13. Q&A

  14. Lunch

  15. Enhesa Product service presentation and platform demo

  16. Borderline products with a focus on treated articles

    • What is a borderline product?
    • Is it a biocide or treated article?
    • Current status: What is available
    • Gaps and challenges: What is missing?
  17. Beyond BPR processes: challenges and experience sharing from the downstream industry – wood preservatives in PT8

    • The invisible challenge: downstream industry constraints 
    • Bridging the timelines: from BPR processes to industry implementation 
    • Case study and learnings: propiconazole 
    • Conclusion 
  18. What are the hidden challenges, especially regarding data protection, from the extension of the review programme?

    • Data protection: the big outstanding question 
    • New data requests 
    • Unbalanced market conditions 
  19. Q&A

  20. Refreshment break

  21. Session 3: Sustainability and the BPR

  22. Moderator

  23. Updates on the high-level round table discussions and the likely impacts of the Reach/CLP reviews on the biocides sector

    • Recent developments in the REACH/CLP review
    • Links between Reach and biocides regulation
    • New hazard classes
    • Possible implications for active substance approval and product authorisation
  24. Implementation of one substance – one assessment (OSOA) and potential impacts for biocides

    • One substance one assessment (1S1A) approach 
    • ECHA ongoing activities to implement 1S1A 
    • What does it mean for biocides? 
    • Illustrative cases 
  25. Experiences with simplified authorisation

    • Introduction: Process and requirements 
    • Eligibility criteria: Importance of composition analysis and evaluation of the hazardous profile of the components 
    • Post authorisation processes: From notifications to the renewal of the authorisation 
  26. Technical and regulatory considerations when integrating sustainability trends for biocides

    • QUATs and disinfectant wipes 
    • Efficacy & labelling 
    • Potential impacts post-authorisation 
  27. Q&A

  28. Networking drinks reception

    Join us for relaxed networking, drinks and appetisers with our speakers and attendees.  

  29. Close of day